ArticleJAMA oncology2020

Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer-Reply.

Zhijie Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.